LFS-1107

Overview

LFS-1107 is a reversible CRM1 inhibitor ( K d : 12.5 pM). LFS-1107 can selectively eliminate extranodal natural killer/T cell lymphoma (ENKTL) cells and can be used for cancer research.

Application

Products | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > CRM1 | Products > Signaling Pathways > COX | Products > Signaling Pathways > c-Myc | Products > Signaling Pathways > Survivin

Product Information

• Catalog No.: HY-157136
• CAS No.: 1799330-91-8
• Molecular Formula: C12H11N5OS2
• Molecular Weight: 305.38
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source